MA53623A - Procédés de traitement du cancer par inhibition de l'enzyme de conjugaison de l'ubiquitine e2 k (ube2k) - Google Patents
Procédés de traitement du cancer par inhibition de l'enzyme de conjugaison de l'ubiquitine e2 k (ube2k)Info
- Publication number
- MA53623A MA53623A MA053623A MA53623A MA53623A MA 53623 A MA53623 A MA 53623A MA 053623 A MA053623 A MA 053623A MA 53623 A MA53623 A MA 53623A MA 53623 A MA53623 A MA 53623A
- Authority
- MA
- Morocco
- Prior art keywords
- ube2k
- inhibition
- cancer
- treatment
- methods
- Prior art date
Links
- 101000644689 Homo sapiens Ubiquitin-conjugating enzyme E2 K Proteins 0.000 title 2
- 102100020696 Ubiquitin-conjugating enzyme E2 K Human genes 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862729348P | 2018-09-10 | 2018-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA53623A true MA53623A (fr) | 2021-07-21 |
Family
ID=69778426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA053623A MA53623A (fr) | 2018-09-10 | 2019-09-10 | Procédés de traitement du cancer par inhibition de l'enzyme de conjugaison de l'ubiquitine e2 k (ube2k) |
Country Status (13)
Country | Link |
---|---|
US (1) | US20210252036A1 (fr) |
EP (1) | EP3849543A4 (fr) |
JP (1) | JP2022500378A (fr) |
KR (1) | KR20210057121A (fr) |
CN (1) | CN112996504A (fr) |
AU (1) | AU2019339896A1 (fr) |
BR (1) | BR112021004417A2 (fr) |
CA (1) | CA3112191A1 (fr) |
IL (1) | IL281327A (fr) |
MA (1) | MA53623A (fr) |
MX (1) | MX2021002818A (fr) |
SG (1) | SG11202102417TA (fr) |
WO (1) | WO2020055906A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11091447B2 (en) * | 2020-01-03 | 2021-08-17 | Berg Llc | UBE2K modulators and methods for their use |
WO2023091590A1 (fr) * | 2021-11-17 | 2023-05-25 | Berg Llc | Composés destinés à être utilisés dans le traitement du cancer de l'estomac |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1784646B1 (fr) * | 2004-08-11 | 2012-06-13 | Albert Einstein College Of Medicine Of Yeshiva University | Procédé d'identification de metastases dans des cellules motiles |
EP2086999B1 (fr) * | 2006-11-02 | 2013-01-09 | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Inhibiteurs pour interrompre l'interaction d'enzymes associées à l'ubiquitinylation et leurs utilisations |
KR101525122B1 (ko) * | 2013-08-05 | 2015-06-03 | 광주과학기술원 | Ubb 넉다운에 의한 암의 예방 또는 치료 |
AU2015219495B2 (en) * | 2014-02-21 | 2019-11-21 | Ibc Pharmaceuticals, Inc. | Disease therapy by inducing immune response to Trop-2 expressing cells |
-
2019
- 2019-09-10 CA CA3112191A patent/CA3112191A1/fr active Pending
- 2019-09-10 WO PCT/US2019/050465 patent/WO2020055906A1/fr unknown
- 2019-09-10 JP JP2021513242A patent/JP2022500378A/ja active Pending
- 2019-09-10 KR KR1020217010620A patent/KR20210057121A/ko unknown
- 2019-09-10 SG SG11202102417TA patent/SG11202102417TA/en unknown
- 2019-09-10 BR BR112021004417-5A patent/BR112021004417A2/pt not_active Application Discontinuation
- 2019-09-10 EP EP19861199.8A patent/EP3849543A4/fr active Pending
- 2019-09-10 MX MX2021002818A patent/MX2021002818A/es unknown
- 2019-09-10 AU AU2019339896A patent/AU2019339896A1/en active Pending
- 2019-09-10 MA MA053623A patent/MA53623A/fr unknown
- 2019-09-10 US US17/274,405 patent/US20210252036A1/en active Pending
- 2019-09-10 CN CN201980073592.0A patent/CN112996504A/zh active Pending
-
2021
- 2021-03-08 IL IL281327A patent/IL281327A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SG11202102417TA (en) | 2021-04-29 |
EP3849543A1 (fr) | 2021-07-21 |
US20210252036A1 (en) | 2021-08-19 |
AU2019339896A1 (en) | 2021-04-08 |
EP3849543A4 (fr) | 2022-11-30 |
BR112021004417A2 (pt) | 2021-06-01 |
CN112996504A (zh) | 2021-06-18 |
WO2020055906A1 (fr) | 2020-03-19 |
IL281327A (en) | 2021-04-29 |
CA3112191A1 (fr) | 2020-03-19 |
WO2020055906A8 (fr) | 2021-01-07 |
MX2021002818A (es) | 2021-07-15 |
KR20210057121A (ko) | 2021-05-20 |
JP2022500378A (ja) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501888A1 (en) | Bromodomain inhibitor | |
MA43746A (fr) | Dérivés de 2-cyanoisoindoline pour le traitement du cancer | |
MA49144A (fr) | Polythérapies pour le traitement du cancer | |
WO2018026722A8 (fr) | Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers | |
PH12018500587A1 (en) | Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer | |
MA41291A (fr) | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer | |
EP4134364A3 (fr) | Inhibiteurs de bromodomaines | |
MA51418A (fr) | Inhibiteurs de glycolate oxydase pour le traitement de maladies | |
EP3866781A4 (fr) | Nouvelles compositions pour le traitement de maladies inflammatoires | |
MX2020011542A (es) | Inhibidores de cd73. | |
MA50409A (fr) | Polythérapies pour le traitement du cancer | |
NZ788133A (en) | Cd73 inhibitors | |
MA47172A (fr) | Compositions et procédés de traitement des inflammations intestinales et du cancer du côlon | |
PH12018501943A1 (en) | Pharmaceutical compositions for the treatment of cancer | |
MA53623A (fr) | Procédés de traitement du cancer par inhibition de l'enzyme de conjugaison de l'ubiquitine e2 k (ube2k) | |
MA54317A (fr) | Procédés de traitement de cancers à surexpression de whsc1 par inhibition de setd2 | |
MA51613A (fr) | Polythérapie pour le traitement ou la prévention du cancer | |
IL283885A (en) | cxcr7 inhibitors for cancer therapy | |
MA56508A (fr) | Inhibiteur d'egfr pour le traitement du cancer | |
MA56429A (fr) | Installation pour le traitement de carrosseries | |
EA201792124A1 (ru) | Биотин для лечения амиотрофического латерального склероза | |
EP3762035A4 (fr) | Compositions et méthodes pour le diagnostic et le traitement du cancer à alt | |
MA55531A (fr) | Procédés pour le traitement de béta-thalassémie | |
MX2021002444A (es) | Compuestos y metodos para el tratamiento de infecciones fungicas. | |
MA55218A (fr) | Eskétamine pour le traitement de la dépression |